Lisinoril
- Product NDC
- 61919-721
- 11-digit product format
- 619190721
- Labeler code
- 61919
- Product ID
- 61919-721_ea4ed022-70d0-b687-e053-2a95a90a9fad
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA076164
- Marketing category
- ANDA
- Marketing start
- 2019-08-28
- Marketing end
- 0000-00-00
- Substance
- LISINOPRIL
- Active strength
- 40 mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61919-721-30 | Lisinoril | 30 in 1 BOTTLE | TABLET | 30 | | 2 |
| 61919-721-90 | Lisinoril | 90 in 1 BOTTLE | TABLET | 90 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61919-721 | LISINORIL (LISINOPRIL) TABLET [DIRECT_RX] | 2 | Legacy NDC, 1 package rows | 20221007_912eeb2b-020b-6d22-e053-2a95a90afbe6.zip |
| 61919-721 | LISINORIL (LISINOPRIL) TABLET [DIRECT_RX] | 1 | Legacy NDC, 1 package rows | 20190214_7f864dbe-4de0-b642-e053-2991aa0afad5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-721-30 | 61919072130 | 30 TABLET in 1 BOTTLE (61919-721-30) | 30 tablet | 2019-08-28 | 0000-00-00 | No | No | Current |
| 61919-721-90 | 61919072190 | 90 TABLET in 1 BOTTLE (61919-721-90) | 90 tablet | 2019-01-15 | 0000-00-00 | No | No | Current |